Skip to content
    Real-World Studies

    Trends and Predictors of Nipple-Sparing Mastectomy in BRCA1/2 and PALB2 Carriers

    Alsuhaibani et alHereditary cancer in clinical practice

    Trends and Predictors of Nipple-Sparing Mastectomy in BRCA1/2 and PALB2 Carriers
    In a retrospective cohort study conducted across two Canadian academic institutions between 2003 and 2024, researchers evaluated surgical trends among 559 female carriers of high-penetrance germline pathogenic variants (GPVs)—primarily BRCA1 (46.7%) and BRCA2 (44.4%), alongside PALB2 and other variants—undergoing risk-reducing mastectomy (RRM). The cohort included 319 affected carriers (57%) with a personal history of breast cancer and 240 unaffected carriers (43%), with an overall median age of 45 years (range 22–76).
    Overall, 55.5% (n = 310) of patients underwent nipple-sparing mastectomy (NSM), 31.1% (n = 174) underwent skin-sparing mastectomy (SSM), and 13.4% (n = 75) underwent total mastectomy (TM). The proportion of patients receiving NSM grew substantially over the study period, rising from 11.9% prior to 2012 to 74.4% after 2022 (p < 0.001). Uptake also varied across age groups, peaking among patients aged 40–49 years at 56% and dropping to 42% in patients aged 60 years or older (p = 0.03).
    Multivariable logistic regression adjusting for age, specific GPV, parity, menopausal status, and personal history of breast cancer revealed that normal BMI (OR 1.99, 95% CI 1.18–3.34), absence of previous radiation exposure (OR 3.03, 95% CI 1.76–5.23), and year of surgery (OR 1.25, 95% CI 1.19–1.32) served as independent predictors of NSM utilization. The authors concluded that there has been a significant increase in the use of NSM as an oncologically safe RRM option for GPV carriers over the past two decades.

    Key Takeaways

    • Uptake of nipple-sparing mastectomy for risk reduction increased from 11.9% pre-2012 to 74.4% after 2022 among high-penetrance germline pathogenic variant carriers (p < 0.001).
    • Multivariable analysis identified normal BMI (OR 1.99, 95% CI 1.18–3.34), lack of radiation exposure (OR 3.03, 95% CI 1.76–5.23), and more recent surgical year (OR 1.25, 95% CI 1.19–1.32) as independent predictors of receiving nipple-sparing mastectomy.
    • Patients with prior breast cancer diagnoses (47% vs. 66%, p < 0.001) and those with prior radiation exposure (34.3% vs. 62.7%, p < 0.001) were significantly less likely to undergo nipple-sparing procedures compared to their unaffected and unexposed counterparts.
    Read the original sourceHereditary cancer in clinical practice